Z4D.SI stock plunged 14.29% to S$0.012 at the SES close on 03 Feb 2026, making Medi Lifestyle Limited one of today’s top losers on the Singapore Exchange. Trading volume reached 399,800.00 shares versus a 50-day average of 938,575.00, signalling heavier selling pressure. Investors should note the one-day drop, the stock’s small market cap and thin liquidity when assessing short-term risk and potential value plays.
Z4D.SI stock: market close snapshot
Medi Lifestyle Limited (Z4D.SI) closed at S$0.012 on the SES in Singapore, down S$0.002 or 14.29% from the previous close of S$0.014. Volume was 399,800.00 versus an average volume of 938,575.00, showing below-average liquidity. The intraday range was tight with both day low and day high at S$0.012.
The company’s year high remains S$0.016 and year low S$0.006, illustrating large historical volatility. Market cap stands at SGD 1,929,629.00 with 160,802,419.00 shares outstanding.
Z4D.SI stock: what moved the price today
The sharp one-day fall appears driven by momentum selling and low liquidity rather than a single headline event. Relative volume stayed low at 0.43 of the average, increasing the price impact of sell orders. Investing.com NG comparison shows scant recent coverage, which can amplify moves in micro-cap names.
Without a clear company announcement, the decline aligns with short-term profit-taking after a 3-month gain of 20.00% and a YTD move of -7.69%. For active traders, the immediate catalyst is order flow and trade size against thin depth on SES.
Z4D.SI stock: fundamentals and valuation
Medi Lifestyle Limited reports negative earnings per share of -0.01 with a trailing PE of -1.20, reflecting recent losses. Price-to-sales is 1.11 and book value per share is negative at -0.013659331 (reported), highlighting weak equity buffers. The current ratio is 0.52, indicating short-term liquidity pressure.
Operational metrics show operating cash flow per share of -0.023500 and free cash flow per share of -0.023500. These figures suggest the company currently consumes cash, increasing reliance on working capital or financing to fund operations.
Z4D.SI stock: technicals and trading outlook
Short-term technicals show the stock trading near its 50-day average of S$0.011 (0.011) and above the 200-day average of S$0.009 (0.009), a mixed picture for momentum traders. RSI at 63.70 and ADX at 42.80 indicate a firm short-term trend but elevated MFI at 93.98 signals possible intraday overbought-to-mean-reversion flow before today’s sell-off.
Important supports and resistances: immediate support sits at the year low S$0.006, representing 50.00% downside from today’s close; initial resistance clusters around the S$0.011–S$0.016 band. Traders should size positions carefully given average daily liquidity.
Meyka AI rates Z4D.SI with a score out of 100 and forecast
Meyka AI rates Z4D.SI with a score of 62.68 out of 100 (Grade B, suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Grades are informational and not financial advice.
Meyka AI’s forecast model projects a short-term target of S$0.020 (monthly) and a 12-month projection of S$0.047. Versus the current S$0.012, the model implies +66.67% upside to the one‑month target and +294.36% to the 12‑month projection. Forecasts are model-based projections and not guarantees.
Z4D.SI stock: risks, catalysts and sector context
Key risks include continued negative operating cash flow, negative book value per share and high volatility from thin trading. Debt and interest coverage metrics show stress: interest coverage at -15.18 and cash per share at 0.001803, which raises refinancing risk if operating losses persist.
Potential catalysts would be clear recovery in the Healthcare segment, earnings improvement, stronger quarterly cash flow, or corporate actions that increase liquidity. Sector peers in Healthcare show average PE near 22.08 and healthier current ratios, so Medi Lifestyle’s weaker metrics warrant caution.
Final Thoughts
Z4D.SI stock was one of today’s top losers on the SES close on 03 Feb 2026, falling 14.29% to S$0.012 on volume of 399,800.00. The drop reflects thin liquidity, recent profit-taking and persistent fundamental weaknesses such as negative EPS (-0.01) and negative book value per share. Meyka AI rates the name 62.68/100 (Grade B, HOLD) and models a S$0.020 one‑month target and a S$0.047 12‑month projection, implying +66.67% and +294.36% upside respectively from today’s price. Balanced investors should weigh the model upside against clear downside: the year low S$0.006 equates to -50.00% from today, underlining high binary risk. Use tight position sizing, confirm catalysts such as improved cash flow or positive earnings, and treat Meyka AI forecasts as model-based guidance rather than guarantees. For active traders, watch the 50‑day trend for early signs of mean reversion or renewed selling pressure.
FAQs
What caused the Z4D.SI stock drop today?
The fall to S$0.012 was likely driven by thin liquidity and momentum selling. Volume was 399,800.00, below the 50-day average, amplifying price moves. No major corporate announcement was published at close.
What is Meyka AI’s forecast for Z4D.SI stock?
Meyka AI’s forecast model projects S$0.020 monthly and S$0.047 at 12 months. Versus S$0.012 today, implied upside is +66.67% (1 month) and +294.36% (12 months). Forecasts are model-based projections and not guarantees.
Is Z4D.SI stock a buy after the decline?
Meyka AI grades Z4D.SI 62.68/100 (Grade B, HOLD). The stock shows high upside in model forecasts but also significant liquidity and fundamental risks. Consider catalysts, risk tolerance and position sizing before buying.
What are the main financial risks for Medi Lifestyle (Z4D.SI)?
Key risks include negative EPS (-0.01), negative book value per share, weak current ratio (0.52) and negative operating cash flow per share (-0.02350). These increase refinancing and operational risks if losses persist.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)